Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Validation of Icobrain Aria - An AI-based Software Tool for Automated Detection and Quantification of Amyloid-related Imaging Abnormalities

              Author:Sima, Diana   Phan, Thanh Vân   Van Eyndhoven, Simon   Vercruyssen, Sophie   Magalhães, Ricardo   Maes, Celine   Khan, Rafay   Guo, Joshua   Hughes, Richard   Gabr, Refaat   Saha-Chaudhuri, Paramita   Curiale, Gioacchino   Belachew, Shibeshih   Van Hecke, Wim   Ribbens, Annemie   Smeets, Dirk   

              Session Name:S1: Alzheimer’s Disease and Related Dementias  

              Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

              Program Number:S1.005  

              Author Institution:icometrix, Leuven, Belgium  Biogen, Boston, MA  Biogen, Cambridge, MA  

              Real-world Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates

              Author:Woodson, Sophia   Gettings, Edward   Guo, Chu-Yueh   Klineova, Sylvia   Lee, Jong-Mi   Romero, Rebecca   Walker, Aljoeson   Fong, Kinyee   Mendoza, Jason   Belviso, Nicholas   Bian, Boyang   Lewin, James   Shankar, Sai   

              Session Name:P4: Multiple Sclerosis: Special Populations  

              Topic:Multiple Sclerosis  

              Program Number:P4.005  

              Author Institution:University Hospitals, Cleveland, OH  Temple Health, Philadelphia, PA  University of California San Francisco Health, San Francisco, CA  Mount Sinai, New York, NY  Stanford Medicine, Palo Alto, CA  University of Texas Health, San Antonio, TX  Medical University of South Carolina, Charleston, SC  Biogen, Cambridge, MA  

              Change in Disease Modifying Therapy from DMF to DRF in People with Multiple Sclerosis and the Impact on CD4/CD8 T Cells

              Author:Rahaman, Fatema   Jo, Matthew   Weller, Joanna   Kaczmarek, Olivia   Jaenicke, Kaitlyn   Baek, Steven   Buhse, Marijean   Bumstead, Barbara   Zarif, Myassar   Mendoza, Jason   Smrtka, Jennifer   Scott, Nicole   Lewin, James   Gudesblatt, Mark   

              Session Name:P8: Multiple Sclerosis: Non-MS CNS Neuroinflammatory Diseases and Progressive MS and Remyelination/Neuroprotection  

              Topic:Multiple Sclerosis  

              Program Number:P8.016  

              Author Institution:South Shore Neurologic Associates, P.C., Patchogue, NY  South Shore Neurologic Associates, P.C., Mount Sinai, NY  Biogen, Cambridge, MA  Biogen, Chapel Hill, NC  Biogen, Seaford, NY  Biogen, Framingham, MA  

              An Investigation of Myelin Streamline Decomposition of Brain Networks in the SYNERGY Trial

              Author:Bosticardo, Sara   Lu, Po-Jui   Tagge, Ian   Zhu, Bing   Schädelin, Sabine   Daducci, Alessandro   Granziera, Cristina   

              Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2  

              Topic:Multiple Sclerosis  

              Program Number:P9.018  

              Author Institution:University of Basel, Basel, Switzerland  Biogen, Cambridge, MA  University of Verona, Verona, Italy  

              Reduced Risk of Progressive Multifocal Leukoencephalopathy (PML) with Natalizumab Extended Interval Dosing (EID) Compared with Every-4-week (Q4W) Dosing: Updated Analysis of the TOUCH® Prescribing Program Database

              Author:Zhovtis Ryerson, Lana   Foley, John   Kister, Ilya   Cutter, Gary   Metzger, Ryan   Goldberg, Judith   Li, Xiaochun   Riddle, Evan   Smirnakis, Karen   Domingo-Horne, Rose   Lasky, Tyler   

              Session Name:P10: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 3  

              Topic:Multiple Sclerosis  

              Program Number:P10.005  

              Author Institution:Jersey Shore University Medical Center, Neptune, NJ  Rocky Mountain MS Clinic, Salt Lake City, UT  NYU Langone Health, New York University, New York, NY  University of Alabama at Birmingham School of Public Health, Birmingham, AL  New York University Grossman School of Medicine, New York, NY  Biogen, Cambridge, MA